Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)

Identifieur interne : 000D77 ( PascalFrancis/Corpus ); précédent : 000D76; suivant : 000D78

Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)

Auteurs : Fabienne Ory-Magne ; Christine Brefel-Courbon ; Pierre Payoux ; Sabrina Debruxelles ; Igor Sibon ; Cyril Goizet ; Pierre Labauge ; Patrice Menegon ; Emmanuelle Uro-Coste ; Bernardino Ghetti ; Marie Bernadetle Delisle ; Ruben Vidal ; Olivier Rascol

Source :

RBID : Pascal:09-0386531

Descripteurs français

English descriptors

Abstract

To describe a family with a hereditary ferritinopathy (HF) due to a mutation in the ferritin light chain gene (FTL498-499InsTC mutation). Case reports of the clinical features, MRI, 18FDG PET, and pathological findings observed in this family with two patients described in more details. Postural tremor (phenotype-1 ) or cerebellar signs (phenotype-2) were the first neurological symptoms detected. Parkinsonian, cerebellar and pyramidal syndromes, abnormal involuntary movements, dementia were observed in both phenotypes at more advanced stages. Beside characteristics T2* hypointense signals suggestive of iron accumulation in the striatum, mesencephalon, and cerebellum, we detected more diffuse changes including cerebellar, cortical and subcortical atrophy, cortical iron deposition, and severe leukoencephalopathy. 18FDG PET showed frontal and cerebellum hypometabolism with more severe frontal defect in patients with cognitive decline. Pathological examination showed ferritin and iron deposition in the liver, kidney, muscle, skin, and in the central nervous system. Members of this family affected by HF due to the FTL498-499InsTC mutation have a specific clinical presentation with initial postural tremor or cerebellar ataxia, followed by pyramidal and extrapyramidal motor syndromes and late severe subcortical dementia.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 24
A06       @2 11
A08 01  1  ENG  @1 Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)
A11 01  1    @1 ORY-MAGNE (Fabienne)
A11 02  1    @1 BREFEL-COURBON (Christine)
A11 03  1    @1 PAYOUX (Pierre)
A11 04  1    @1 DEBRUXELLES (Sabrina)
A11 05  1    @1 SIBON (Igor)
A11 06  1    @1 GOIZET (Cyril)
A11 07  1    @1 LABAUGE (Pierre)
A11 08  1    @1 MENEGON (Patrice)
A11 09  1    @1 URO-COSTE (Emmanuelle)
A11 10  1    @1 GHETTI (Bernardino)
A11 11  1    @1 BERNADETLE DELISLE (Marie)
A11 12  1    @1 VIDAL (Ruben)
A11 13  1    @1 RASCOL (Olivier)
A14 01      @1 Department of Neurosciences, University Hospital of Toulouse @2 Toulouse @3 FRA @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 13 aut.
A14 02      @1 Department of Nuclear Medicine, University Hospital of Toulouse @2 Toulouse @3 FRA @Z 3 aut.
A14 03      @1 Department of Neurology, University Hospital of Bordeaux @2 Bordeaux @3 FRA @Z 5 aut. @Z 6 aut.
A14 04      @1 Department of Neurology, University Hospital of Montpellier @2 Montpellier @3 FRA @Z 7 aut.
A14 05      @1 Department of Neuroradiology, University Hospital of Bordeaux @2 Bordeaux @3 FRA @Z 8 aut.
A14 06      @1 Department of Pathology, University Hospital of Toulouse @2 Toulouse @3 FRA @Z 9 aut. @Z 11 aut.
A14 07      @1 Department of Pathology and Laboratory Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine @2 Indianapolis, Indiana @3 USA @Z 10 aut. @Z 12 aut.
A14 08      @1 Department of Clinical Pharmacology, Clinical Investigation Center, University Hospital of Toulouse @2 Toulouse @3 FRA @Z 13 aut.
A20       @1 1676-1683
A21       @1 2009
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000171892190170
A44       @0 0000 @1 © 2009 INIST-CNRS. All rights reserved.
A45       @0 14 ref.
A47 01  1    @0 09-0386531
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 To describe a family with a hereditary ferritinopathy (HF) due to a mutation in the ferritin light chain gene (FTL498-499InsTC mutation). Case reports of the clinical features, MRI, 18FDG PET, and pathological findings observed in this family with two patients described in more details. Postural tremor (phenotype-1 ) or cerebellar signs (phenotype-2) were the first neurological symptoms detected. Parkinsonian, cerebellar and pyramidal syndromes, abnormal involuntary movements, dementia were observed in both phenotypes at more advanced stages. Beside characteristics T2* hypointense signals suggestive of iron accumulation in the striatum, mesencephalon, and cerebellum, we detected more diffuse changes including cerebellar, cortical and subcortical atrophy, cortical iron deposition, and severe leukoencephalopathy. 18FDG PET showed frontal and cerebellum hypometabolism with more severe frontal defect in patients with cognitive decline. Pathological examination showed ferritin and iron deposition in the liver, kidney, muscle, skin, and in the central nervous system. Members of this family affected by HF due to the FTL498-499InsTC mutation have a specific clinical presentation with initial postural tremor or cerebellar ataxia, followed by pyramidal and extrapyramidal motor syndromes and late severe subcortical dementia.
C02 01  X    @0 002B17
C02 02  X    @0 002B17H
C03 01  X  FRE  @0 Pathologie du système nerveux @5 01
C03 01  X  ENG  @0 Nervous system diseases @5 01
C03 01  X  SPA  @0 Sistema nervioso patología @5 01
C03 02  X  FRE  @0 Phénotype @5 09
C03 02  X  ENG  @0 Phenotype @5 09
C03 02  X  SPA  @0 Fenotipo @5 09
C03 03  X  FRE  @0 Français @5 10
C03 03  X  ENG  @0 French @5 10
C03 03  X  SPA  @0 Francés @5 10
C03 04  X  FRE  @0 Fer @2 NC @5 11
C03 04  X  ENG  @0 Iron @2 NC @5 11
C03 04  X  SPA  @0 Hierro @2 NC @5 11
C03 05  X  FRE  @0 Ferritine @5 12
C03 05  X  ENG  @0 Ferritin @5 12
C03 05  X  SPA  @0 Ferritina @5 12
C03 06  X  FRE  @0 Noyau gris central @5 13
C03 06  X  ENG  @0 Basal ganglion @5 13
C03 06  X  SPA  @0 Núcleo basal @5 13
C07 01  X  FRE  @0 Encéphale @5 37
C07 01  X  ENG  @0 Encephalon @5 37
C07 01  X  SPA  @0 Encéfalo @5 37
C07 02  X  FRE  @0 Système nerveux central @5 38
C07 02  X  ENG  @0 Central nervous system @5 38
C07 02  X  SPA  @0 Sistema nervioso central @5 38
N21       @1 278
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 09-0386531 INIST
ET : Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)
AU : ORY-MAGNE (Fabienne); BREFEL-COURBON (Christine); PAYOUX (Pierre); DEBRUXELLES (Sabrina); SIBON (Igor); GOIZET (Cyril); LABAUGE (Pierre); MENEGON (Patrice); URO-COSTE (Emmanuelle); GHETTI (Bernardino); BERNADETLE DELISLE (Marie); VIDAL (Ruben); RASCOL (Olivier)
AF : Department of Neurosciences, University Hospital of Toulouse/Toulouse/France (1 aut., 2 aut., 4 aut., 13 aut.); Department of Nuclear Medicine, University Hospital of Toulouse/Toulouse/France (3 aut.); Department of Neurology, University Hospital of Bordeaux/Bordeaux/France (5 aut., 6 aut.); Department of Neurology, University Hospital of Montpellier/Montpellier/France (7 aut.); Department of Neuroradiology, University Hospital of Bordeaux/Bordeaux/France (8 aut.); Department of Pathology, University Hospital of Toulouse/Toulouse/France (9 aut., 11 aut.); Department of Pathology and Laboratory Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine/Indianapolis, Indiana/Etats-Unis (10 aut., 12 aut.); Department of Clinical Pharmacology, Clinical Investigation Center, University Hospital of Toulouse/Toulouse/France (13 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 11; Pp. 1676-1683; Bibl. 14 ref.
LA : Anglais
EA : To describe a family with a hereditary ferritinopathy (HF) due to a mutation in the ferritin light chain gene (FTL498-499InsTC mutation). Case reports of the clinical features, MRI, 18FDG PET, and pathological findings observed in this family with two patients described in more details. Postural tremor (phenotype-1 ) or cerebellar signs (phenotype-2) were the first neurological symptoms detected. Parkinsonian, cerebellar and pyramidal syndromes, abnormal involuntary movements, dementia were observed in both phenotypes at more advanced stages. Beside characteristics T2* hypointense signals suggestive of iron accumulation in the striatum, mesencephalon, and cerebellum, we detected more diffuse changes including cerebellar, cortical and subcortical atrophy, cortical iron deposition, and severe leukoencephalopathy. 18FDG PET showed frontal and cerebellum hypometabolism with more severe frontal defect in patients with cognitive decline. Pathological examination showed ferritin and iron deposition in the liver, kidney, muscle, skin, and in the central nervous system. Members of this family affected by HF due to the FTL498-499InsTC mutation have a specific clinical presentation with initial postural tremor or cerebellar ataxia, followed by pyramidal and extrapyramidal motor syndromes and late severe subcortical dementia.
CC : 002B17; 002B17H
FD : Pathologie du système nerveux; Phénotype; Français; Fer; Ferritine; Noyau gris central
FG : Encéphale; Système nerveux central
ED : Nervous system diseases; Phenotype; French; Iron; Ferritin; Basal ganglion
EG : Encephalon; Central nervous system
SD : Sistema nervioso patología; Fenotipo; Francés; Hierro; Ferritina; Núcleo basal
LO : INIST-20953.354000171892190170
ID : 09-0386531

Links to Exploration step

Pascal:09-0386531

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)</title>
<author>
<name sortKey="Ory Magne, Fabienne" sort="Ory Magne, Fabienne" uniqKey="Ory Magne F" first="Fabienne" last="Ory-Magne">Fabienne Ory-Magne</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurosciences, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Brefel Courbon, Christine" sort="Brefel Courbon, Christine" uniqKey="Brefel Courbon C" first="Christine" last="Brefel-Courbon">Christine Brefel-Courbon</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurosciences, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Payoux, Pierre" sort="Payoux, Pierre" uniqKey="Payoux P" first="Pierre" last="Payoux">Pierre Payoux</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Nuclear Medicine, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Debruxelles, Sabrina" sort="Debruxelles, Sabrina" uniqKey="Debruxelles S" first="Sabrina" last="Debruxelles">Sabrina Debruxelles</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurosciences, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Sibon, Igor" sort="Sibon, Igor" uniqKey="Sibon I" first="Igor" last="Sibon">Igor Sibon</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, University Hospital of Bordeaux</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Goizet, Cyril" sort="Goizet, Cyril" uniqKey="Goizet C" first="Cyril" last="Goizet">Cyril Goizet</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, University Hospital of Bordeaux</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Labauge, Pierre" sort="Labauge, Pierre" uniqKey="Labauge P" first="Pierre" last="Labauge">Pierre Labauge</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurology, University Hospital of Montpellier</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Menegon, Patrice" sort="Menegon, Patrice" uniqKey="Menegon P" first="Patrice" last="Menegon">Patrice Menegon</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Neuroradiology, University Hospital of Bordeaux</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Uro Coste, Emmanuelle" sort="Uro Coste, Emmanuelle" uniqKey="Uro Coste E" first="Emmanuelle" last="Uro-Coste">Emmanuelle Uro-Coste</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Pathology, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ghetti, Bernardino" sort="Ghetti, Bernardino" uniqKey="Ghetti B" first="Bernardino" last="Ghetti">Bernardino Ghetti</name>
<affiliation>
<inist:fA14 i1="07">
<s1>Department of Pathology and Laboratory Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bernadetle Delisle, Marie" sort="Bernadetle Delisle, Marie" uniqKey="Bernadetle Delisle M" first="Marie" last="Bernadetle Delisle">Marie Bernadetle Delisle</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Pathology, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Vidal, Ruben" sort="Vidal, Ruben" uniqKey="Vidal R" first="Ruben" last="Vidal">Ruben Vidal</name>
<affiliation>
<inist:fA14 i1="07">
<s1>Department of Pathology and Laboratory Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurosciences, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="08">
<s1>Department of Clinical Pharmacology, Clinical Investigation Center, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">09-0386531</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0386531 INIST</idno>
<idno type="RBID">Pascal:09-0386531</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D77</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)</title>
<author>
<name sortKey="Ory Magne, Fabienne" sort="Ory Magne, Fabienne" uniqKey="Ory Magne F" first="Fabienne" last="Ory-Magne">Fabienne Ory-Magne</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurosciences, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Brefel Courbon, Christine" sort="Brefel Courbon, Christine" uniqKey="Brefel Courbon C" first="Christine" last="Brefel-Courbon">Christine Brefel-Courbon</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurosciences, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Payoux, Pierre" sort="Payoux, Pierre" uniqKey="Payoux P" first="Pierre" last="Payoux">Pierre Payoux</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Nuclear Medicine, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Debruxelles, Sabrina" sort="Debruxelles, Sabrina" uniqKey="Debruxelles S" first="Sabrina" last="Debruxelles">Sabrina Debruxelles</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurosciences, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Sibon, Igor" sort="Sibon, Igor" uniqKey="Sibon I" first="Igor" last="Sibon">Igor Sibon</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, University Hospital of Bordeaux</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Goizet, Cyril" sort="Goizet, Cyril" uniqKey="Goizet C" first="Cyril" last="Goizet">Cyril Goizet</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, University Hospital of Bordeaux</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Labauge, Pierre" sort="Labauge, Pierre" uniqKey="Labauge P" first="Pierre" last="Labauge">Pierre Labauge</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurology, University Hospital of Montpellier</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Menegon, Patrice" sort="Menegon, Patrice" uniqKey="Menegon P" first="Patrice" last="Menegon">Patrice Menegon</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Neuroradiology, University Hospital of Bordeaux</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Uro Coste, Emmanuelle" sort="Uro Coste, Emmanuelle" uniqKey="Uro Coste E" first="Emmanuelle" last="Uro-Coste">Emmanuelle Uro-Coste</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Pathology, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ghetti, Bernardino" sort="Ghetti, Bernardino" uniqKey="Ghetti B" first="Bernardino" last="Ghetti">Bernardino Ghetti</name>
<affiliation>
<inist:fA14 i1="07">
<s1>Department of Pathology and Laboratory Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bernadetle Delisle, Marie" sort="Bernadetle Delisle, Marie" uniqKey="Bernadetle Delisle M" first="Marie" last="Bernadetle Delisle">Marie Bernadetle Delisle</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Pathology, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Vidal, Ruben" sort="Vidal, Ruben" uniqKey="Vidal R" first="Ruben" last="Vidal">Ruben Vidal</name>
<affiliation>
<inist:fA14 i1="07">
<s1>Department of Pathology and Laboratory Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurosciences, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="08">
<s1>Department of Clinical Pharmacology, Clinical Investigation Center, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Basal ganglion</term>
<term>Ferritin</term>
<term>French</term>
<term>Iron</term>
<term>Nervous system diseases</term>
<term>Phenotype</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Pathologie du système nerveux</term>
<term>Phénotype</term>
<term>Français</term>
<term>Fer</term>
<term>Ferritine</term>
<term>Noyau gris central</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">To describe a family with a hereditary ferritinopathy (HF) due to a mutation in the ferritin light chain gene (FTL498-499InsTC mutation). Case reports of the clinical features, MRI,
<sup>18</sup>
FDG PET, and pathological findings observed in this family with two patients described in more details. Postural tremor (phenotype-1 ) or cerebellar signs (phenotype-2) were the first neurological symptoms detected. Parkinsonian, cerebellar and pyramidal syndromes, abnormal involuntary movements, dementia were observed in both phenotypes at more advanced stages. Beside characteristics T2
<sup>*</sup>
hypointense signals suggestive of iron accumulation in the striatum, mesencephalon, and cerebellum, we detected more diffuse changes including cerebellar, cortical and subcortical atrophy, cortical iron deposition, and severe leukoencephalopathy.
<sup>18</sup>
FDG PET showed frontal and cerebellum hypometabolism with more severe frontal defect in patients with cognitive decline. Pathological examination showed ferritin and iron deposition in the liver, kidney, muscle, skin, and in the central nervous system. Members of this family affected by HF due to the FTL498-499InsTC mutation have a specific clinical presentation with initial postural tremor or cerebellar ataxia, followed by pyramidal and extrapyramidal motor syndromes and late severe subcortical dementia.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>24</s2>
</fA05>
<fA06>
<s2>11</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>ORY-MAGNE (Fabienne)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>BREFEL-COURBON (Christine)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>PAYOUX (Pierre)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>DEBRUXELLES (Sabrina)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>SIBON (Igor)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>GOIZET (Cyril)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>LABAUGE (Pierre)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>MENEGON (Patrice)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>URO-COSTE (Emmanuelle)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>GHETTI (Bernardino)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>BERNADETLE DELISLE (Marie)</s1>
</fA11>
<fA11 i1="12" i2="1">
<s1>VIDAL (Ruben)</s1>
</fA11>
<fA11 i1="13" i2="1">
<s1>RASCOL (Olivier)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Neurosciences, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Nuclear Medicine, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Department of Neurology, University Hospital of Bordeaux</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Department of Neurology, University Hospital of Montpellier</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Department of Neuroradiology, University Hospital of Bordeaux</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Department of Pathology, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Department of Pathology and Laboratory Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="08">
<s1>Department of Clinical Pharmacology, Clinical Investigation Center, University Hospital of Toulouse</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA20>
<s1>1676-1683</s1>
</fA20>
<fA21>
<s1>2009</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000171892190170</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>14 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>09-0386531</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>To describe a family with a hereditary ferritinopathy (HF) due to a mutation in the ferritin light chain gene (FTL498-499InsTC mutation). Case reports of the clinical features, MRI,
<sup>18</sup>
FDG PET, and pathological findings observed in this family with two patients described in more details. Postural tremor (phenotype-1 ) or cerebellar signs (phenotype-2) were the first neurological symptoms detected. Parkinsonian, cerebellar and pyramidal syndromes, abnormal involuntary movements, dementia were observed in both phenotypes at more advanced stages. Beside characteristics T2
<sup>*</sup>
hypointense signals suggestive of iron accumulation in the striatum, mesencephalon, and cerebellum, we detected more diffuse changes including cerebellar, cortical and subcortical atrophy, cortical iron deposition, and severe leukoencephalopathy.
<sup>18</sup>
FDG PET showed frontal and cerebellum hypometabolism with more severe frontal defect in patients with cognitive decline. Pathological examination showed ferritin and iron deposition in the liver, kidney, muscle, skin, and in the central nervous system. Members of this family affected by HF due to the FTL498-499InsTC mutation have a specific clinical presentation with initial postural tremor or cerebellar ataxia, followed by pyramidal and extrapyramidal motor syndromes and late severe subcortical dementia.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17H</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Phénotype</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Phenotype</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Fenotipo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Français</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>French</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Francés</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Fer</s0>
<s2>NC</s2>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Iron</s0>
<s2>NC</s2>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Hierro</s0>
<s2>NC</s2>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Ferritine</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Ferritin</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Ferritina</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Noyau gris central</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Basal ganglion</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Núcleo basal</s0>
<s5>13</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Encephalon</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Encéfalo</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux central</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Central nervous system</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso central</s0>
<s5>38</s5>
</fC07>
<fN21>
<s1>278</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 09-0386531 INIST</NO>
<ET>Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)</ET>
<AU>ORY-MAGNE (Fabienne); BREFEL-COURBON (Christine); PAYOUX (Pierre); DEBRUXELLES (Sabrina); SIBON (Igor); GOIZET (Cyril); LABAUGE (Pierre); MENEGON (Patrice); URO-COSTE (Emmanuelle); GHETTI (Bernardino); BERNADETLE DELISLE (Marie); VIDAL (Ruben); RASCOL (Olivier)</AU>
<AF>Department of Neurosciences, University Hospital of Toulouse/Toulouse/France (1 aut., 2 aut., 4 aut., 13 aut.); Department of Nuclear Medicine, University Hospital of Toulouse/Toulouse/France (3 aut.); Department of Neurology, University Hospital of Bordeaux/Bordeaux/France (5 aut., 6 aut.); Department of Neurology, University Hospital of Montpellier/Montpellier/France (7 aut.); Department of Neuroradiology, University Hospital of Bordeaux/Bordeaux/France (8 aut.); Department of Pathology, University Hospital of Toulouse/Toulouse/France (9 aut., 11 aut.); Department of Pathology and Laboratory Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine/Indianapolis, Indiana/Etats-Unis (10 aut., 12 aut.); Department of Clinical Pharmacology, Clinical Investigation Center, University Hospital of Toulouse/Toulouse/France (13 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 11; Pp. 1676-1683; Bibl. 14 ref.</SO>
<LA>Anglais</LA>
<EA>To describe a family with a hereditary ferritinopathy (HF) due to a mutation in the ferritin light chain gene (FTL498-499InsTC mutation). Case reports of the clinical features, MRI,
<sup>18</sup>
FDG PET, and pathological findings observed in this family with two patients described in more details. Postural tremor (phenotype-1 ) or cerebellar signs (phenotype-2) were the first neurological symptoms detected. Parkinsonian, cerebellar and pyramidal syndromes, abnormal involuntary movements, dementia were observed in both phenotypes at more advanced stages. Beside characteristics T2
<sup>*</sup>
hypointense signals suggestive of iron accumulation in the striatum, mesencephalon, and cerebellum, we detected more diffuse changes including cerebellar, cortical and subcortical atrophy, cortical iron deposition, and severe leukoencephalopathy.
<sup>18</sup>
FDG PET showed frontal and cerebellum hypometabolism with more severe frontal defect in patients with cognitive decline. Pathological examination showed ferritin and iron deposition in the liver, kidney, muscle, skin, and in the central nervous system. Members of this family affected by HF due to the FTL498-499InsTC mutation have a specific clinical presentation with initial postural tremor or cerebellar ataxia, followed by pyramidal and extrapyramidal motor syndromes and late severe subcortical dementia.</EA>
<CC>002B17; 002B17H</CC>
<FD>Pathologie du système nerveux; Phénotype; Français; Fer; Ferritine; Noyau gris central</FD>
<FG>Encéphale; Système nerveux central</FG>
<ED>Nervous system diseases; Phenotype; French; Iron; Ferritin; Basal ganglion</ED>
<EG>Encephalon; Central nervous system</EG>
<SD>Sistema nervioso patología; Fenotipo; Francés; Hierro; Ferritina; Núcleo basal</SD>
<LO>INIST-20953.354000171892190170</LO>
<ID>09-0386531</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D77 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000D77 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:09-0386531
   |texte=   Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024